An innovative new treatment for melanoma that uses patches embedded with microneedles to deliver anti-PD-1 antibodies and effectively target melanoma has proven successful in animal models. Currently, immunotherapy treatments that target these antibodies have difficulty getting to the targeted tumor site because they are injected into the bloodstream, not the tumor.
Tested using a mouse model, this new patch-style treatment is placed on the skin (like a sticker or bandage). The nanoparticles have been specifically designed to break-down slowly, releasing the anti-bodies directly into the melanoma site over a specific period of time. After 40 days, the survival rate of the subjects with the patch was significantly better than the control groups.
More studies, including clinical studies, will soon be performed to further test this new technology, but based on these animal studies, scientists believe this treatment could become the most effective immunotherapy model for melanoma treatment in the future!
Find out more details on the study: http://practicaldermatology.com/dermwire/2016/03/25/take-that-melanoma-new-patch-delivers-anti-pd-1-antibodies-directly-to-skin-cancer/?c=576&t